Showing results (211-220 of 2,393) with videos related to

Sort By:
Pageof 240
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 26, 1999
Pregnancy in women receiving renal dialysis or transplantation in Japan: a nationwide surveyH Toma, K Tanabe, T Tokumoto, et al.
The Biochemical Journal|February 15, 2001
LIM-kinase 2 induces formation of stress fibres, focal adhesions and membrane blebs, dependent on its activation by Rho-associated kinase-catalysed phosphorylation at threonine-505T Amano, K Tanabe, T Eto, et al.
Experimental Parasitology|May 1, 1990
Plasmodium chabaudi: in vivo effects of Ca2+ antagonists on chloroquine-resistant and chloroquine-sensitive parasitesK Tanabe, M Kato, A Izumo, et al.
Bulletin of the World Health Organization|January 1, 1977
Interactions of rodent malarial parasites with Friend erythroleukemia cells in vitroH Eisen, M Furusawa, K Tanabe, et al.
Diabetologia|January 26, 2008
Mice with beta cell overexpression of glycogen synthase kinase-3beta have reduced beta cell mass and proliferationZ Liu, K Tanabe, E Bernal-Mizrachi, et al.
Advances in Therapy|February 24, 2001
Effect of anti-infective ophthalmic solutions on corneal cells in vitroS Matsumoto, M E Stern
Current Opinion in Organ Transplantation|June 22, 2026
Intestinal transplantation for tumorsCal S Matsumoto, Sukanya Subramanian
The Journal of Biological Chemistry|July 13, 2000
Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A, and SUR2BM Matsuo, K Tanabe, N Kioka, et al.
Oncology Reports|April 11, 2001
A phase II trial of mitomycin C, 5'-deoxy-5-fluorouridine, etoposide and medroxyprogesterone acetate (McVD-MPA) as a salvage chemotherapy to anthracycline-resistant tumor in relapsed breast cancer and its mechanism(s) of antitumor actionR Kim, A Osaki, K Tanabe, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 8, 2011
Chronic antibody-mediated rejection is reduced by targeting B-cell immunity during an introductory periodN Kohei, T Hirai, K Omoto, et al.
Pageof 240